Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.08p
   
  • Change Today:
    -0.17p
  • 52 Week High: 45.20
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 134.41m
  • Volume: 173,298
  • Market Cap: £18.93m
  • RiskGrade: 594
  • Beta: 0.01

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 9.1  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 n/a (3.76) (2.22)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Initiation of Toxicology Studies for SDC-1801 29-May-2025 07:00 RNS
Update on TYK2/JAK1 and SRA737 Programmes 28-Apr-2025 07:00 RNS
Exercise of Warrants 24-Apr-2025 07:00 RNS

Sareum Holdings ShareCast News

Sareum starts toxicology studies for lead inhibi... 29-May-2025 ShareCast
Sareum shares drop on product licence termination 31-Dec-2024 ShareCast
Sareum shares rise on China patent allowance 16-Sep-2024 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 14.08p
Change Today -0.17p
% Change -1.17 %
52 Week High 45.20
52 Week Low 11.25
Volume 173,298
Shares Issued 134.41m
Market Cap £18.93m
Beta 0.01
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.6% below the market average45.6% below the market average45.6% below the market average45.6% below the market average45.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
92.21% below the market average92.21% below the market average92.21% below the market average92.21% below the market average92.21% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
16:06 40,000 @ 14.00p
14:57 13,731 @ 14.50p
13:34 1,500 @ 14.49p
13:32 2,546 @ 14.22p
13:06 3,461 @ 14.22p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page